SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001811764-22-000064
Filing Date
2022-08-12
Accepted
2022-08-12 08:19:42
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pnt-20220630.htm   iXBRL 10-Q 1187320
2 EX-10.1 exhibit101-fapiradiopharma.htm EX-10.1 18172
3 EX-31.1 exhibit311-10qx06302022.htm EX-31.1 11442
4 EX-31.2 exhibit312-10qx06302022.htm EX-31.2 12185
5 EX-32 exhibit32-10qx06302022.htm EX-32 8941
  Complete submission text file 0001811764-22-000064.txt   5937992

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pnt-20220630.xsd EX-101.SCH 43938
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pnt-20220630_cal.xml EX-101.CAL 60322
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pnt-20220630_def.xml EX-101.DEF 220941
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pnt-20220630_lab.xml EX-101.LAB 526549
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pnt-20220630_pre.xml EX-101.PRE 359566
70 EXTRACTED XBRL INSTANCE DOCUMENT pnt-20220630_htm.xml XML 867476
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39373 | Film No.: 221157917
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences